This is in contrast to increased levels of serum, sputum and BAL IL-1β,32–35 and plasma and sputum IL-1836, 37 reported in patients with COPD compared with control smokers and non-smokers. This evidence concerns the gene IL1B and chronic obstructive pulmonary disease.